Drug Discovery Update:
WCK 5222 (ZAYNICH): We continue to recruit more patients for our global clinical trial and
have recruited 392 patients. Recruitment of more than 100 patients has been done during the
current quarter. Clinical Trial study progressing in 9 countries. We have completed 30 patients
for compassionate use after approval of usage by DCGI. The product resulted in 100% cure
and was found to be safe even when administered upto 60 days.
Meropenem Resistance Clinical Trial: DCGI has advised to do a Clinical Trial of 60 patients
study. Patient recruitment process has been initiated. This Clinical Trial would be completed
within the next 8 to 9 months post which WCK 5222 (ZAYNICH) can be launched in India by
early 2025.
WCK 4873 (MIQNAF): The Company is pleased to announce the completion of the pivotal
Phase 3 pneumonia study of its antibiotic Nafithromycin WCK 4873 (MIQNAF). The product
has been filed for DCGI approval which is expected in the Q3FY25. Commercial launch
expected in Q4FY25.
After 30 years, a new oral antibiotic MIQNAF (WCK 4873) will be shortly introduced in India
and it is for Community Acquired Pneumonia with a success rate of over 97%. This will meet
a major antibiotic community need as existing drugs like Azithromycin has high resistance of
60%. It is only a three-day treatment and it has eight times higher lung concentration than
Azithromycin
https://www.bseindia.com/xml-data/corpfiling/AttachLive/f975f9fc-b6fd-4fd7-972e-c8a1ca66ad3e.pdf
Posts in category Value Pickr
Wockhardt – A story with twist and turn (29-05-2024)
PDS Limited – A platform for entrepreneurs (29-05-2024)
I would say PDS is operating in a cyclical industry that’s going through a downcycle. Demand is yet to be revived. Poor cycle brings with it a lot of opportunities as well. The company has been able to increase its stake in many manufacturing companies( esp in Sri Lanka. They have also been able to sign many sourcing agreements with major brands. I would say PDS is in a growth phase now and with the cycle turning so will its fortunes.
Discl: Invested. Have purchases in last 30 days
Bull therapy 101-thread for technical analysis with the fundamentals (29-05-2024)
AVG
Last leg has begun ,it seems .
DHP India Ltd – Regulators and Fittings (29-05-2024)
DHP performance in FY 2024 has been highly disappointing.
1. EBIT margin fell from 28% in FY 2023 to 7% in FY2024
2. Sales dropped by ~51% (from Rs 109Cr to Rs 53Cr this year)
3. What intrigued me the most is that despite the drop in sales and EBIT margin, the net profit and
EPS increased by ~12.7%. Upon digging further I observed two things:
a) Other income increased from Rs 1.6Cr in FY2023 to Rs 26.9Cr in FY2024. This means almost all of the net profit of Rs 26.4Cr is driven by this increase in other income.
b) The tax rate in dropped ~25.8% in FY2023 to ~13.5% in FY2024.
There are two primary conclusions from these observations:
- The quality of earnings deteriorated considerably. Has the management played around with the numbers of other income and tax% to boost earnings? I am compelled to believe that this is indeed the case.
- The firm does not have a moat. At least not as strong or as wide as one would like to think. I think that the business fundamentals have deteriorated considerably. The drastic drop in EBIT and EBITDA margins indicates this. The last time the firm faced strong headwinds was in 2020. But even then it was able to maintain EBIT margin at ~21.3%
Counterviews invited.
Subex Ltd. – Possible Turnaround? (29-05-2024)
this is a great analysis.
Power Mech Projects – Not a typical Power Infra Company (29-05-2024)
Order from BHEL.
Steel Strips Wheels Limited – Attractive Valuations (29-05-2024)
Debt levels are comfortable and they can service it with surplus cash flows and internal accruals which they have already said in their earnings call. I still feel it is undervalued considering the valuation of Wheels India. Holding it.
INOX Wind (29-05-2024)
They did clarify that it will be infused back to IWL.
ef7faa40-3f75-49ff-899c-7898dea6bd55.pdf (871.4 KB)
" Inox Wind Energy Limited raises ~ Rs. 900 Crore through Sale of Equity Shares of Inox Wind Limited; significant step towards completely deleveraging external debt in IWL
• Inox Wind Energy Limited (IWEL), the promoter of Inox Wind (IWL), successfully raised ~ Rs. 900 Crores through sale of equity shares of Inox Wind via block deals on the stock exchanges
• Transaction witnessed strong participation across marquee Institutional Investors"
The funds raised are proposed to be infused into Inox Wind Ltd to pare down Inox Wind’s debt and augment the working capital needs of the company thereby strengthening its balance sheet further.
Companies With First ever concalls OR Investor Presentations (29-05-2024)
Anlon Technology conducted 1st concall yesterday, Good insights about an SME company in a niche segments. Here’s the recording:
INOX Wind (29-05-2024)
You will keep holding this till election results or after that?